Charles River Laboratories | 现金及等价物



金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.57B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
USD 43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


现金及等价物 更改 日
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1B 103.43M 2025-09
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cigna USD 7.68B 1.65B 2025-12
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
CVS Health USD 8.45B 645M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 363M 4M 2025-09
Elevance Health USD 9.49B 778M 2025-12
Galapagos EUR 64.46M 43.61M 2025-09
Hologic USD 2.17B 208.5M 2025-12
Humana USD 4.2B 1.19B 2025-12
Illumina USD 1.42B 368M 2025-12
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Lonza CHF 1.11B 286M 2024-12
McKesson USD 2.96B 1.05B 2025-12
Merck EUR 1.17B 161M 2025-06
Mettler Toledo International USD 69.06M 7.24M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Quest Diagnostics USD 420M 12M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
United Therapeutics USD 1.56B 217M 2025-12
UnitedHealth USD 28.12B 2.49B 2025-12
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 791.3M 162.8M 2025-12


Charles River Laboratories 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.